Fisher Center Foundation For Alzheimer's Research Donate Now to Alzheimer's  

ABOUT US    COMMUNITY    GET INVOLVED    E-NEWSLETTER    CONTACT US    PRESERVING YOUR MEMORY MAGAZINE    ASK THE EXPERTS
Select Text Size: a a a
Search  Go
         
Home > Alzheimer's Disease News


Popular Drugs Can Impair Memory

Mon, 09 Mar 2009 12:09:00 PM EST

Medications commonly prescribed to seniors with a wide range of medical complaints can impair memory, a new study reports. The research is an important reminder that when considering the cause of memory complaints in older people, medications should be carefully considered.

 

The study, of 500 relatively healthy men aged 65 and older with high blood pressure, looked at a class of medications called anticholinergics, which affect many areas of the body. Anticholinergic drugs are used to treat everything from respiratory complaints like asthma to gastrointestinal problems, hypertension and depression. The findings were published in the Journal of the American Geriatrics Society.

 

Anticholintergic drugs block the action of a brain chemical called acetylcholine. Among the drugs in this class are the anxiety fighter Xanax (alprazolam), the antidepressants Asendin (amoxapine) and Elavil (amitriptyline), the high blood pressure medicine Lasix (furosemide), the heart medicine Lanoxin (digoxin), the asthma reliever theophylline, and the Parkinson disease drug Norflex (orphenadrine).

 

Seniors are particularly susceptible to memory problems from these drugs because they often take multiple medications, both prescription and over-the-counter, that can impair memory. In addition, their bodies may not process drugs as efficiently as a younger person would. In some cases, drug-induced forgetfulness and cloudy thinking can appear similar to the early stages of Alzheimer’s disease.

 

The study found that many older men taking anticholinergic drugs long-term had trouble with daily tasks like shopping and managing finances. The higher the dose of drugs they were taking, the more likely -- and the more severe -- the memory deficits.

"This study extends our previous findings on acute cognitive impairment following recent anticholinergic exposure in older medical inpatients," said study author Dr. Ling Han of the Yale University School of Medicine. "Prescribing for older adults who take multiple prescription and over-the-counter medications requires careful attention to minimize the risk of potential harm from the drugs while maximizing their health benefits."

 

Other studies have reported similar problems related to anticholinergic drugs. Importantly, despite memory problems, seniors taking these drugs were not at increased risk of Alzheimer’s.

 

It’s important to consider drug side effects as a possible cause of memory problems in seniors. In many cases, other medicines can be used, and mental deficits can be reversed.

 

It might be possible to reduce a patient's use of anticholinergic drugs, especially in cases where a patient might have been over-medicated.

Seniors who are taking these drugs, however, should not stop taking them or reduce the dose on their own, because they may be necessary for the patient's health. However, patients should discuss side effects on memory and other body systems with their doctors.

 

By ALZinfo.org. Reviewed by William J. Netzer, Ph.D., Fisher Center for Alzheimer's Research Foundation at The Rockefeller University

 

Han et al. Cumulative Anticholinergic Exposure Is Associated with Poor Memory and Executive Function in Older Men. Journal of the American Geriatrics Society, 2008; 56 (12): 2203

Related Alzheimer's Prevention and Wellness Articles

Mediterranean Diet Helps Ward Off Memory Loss
Read More
Education Lowers Alzheimer’s Risk, But Not Rate of Mental Decline
Read More
Outgoing, Relaxed People May Be Less Likely to Get Alzheimer's
Read More

Rate Article:
Add RSS Feed:
  News Feeds
Embed Code :
 
Credits/Terms of Service/Privacy Policy/Alzheimer's Glossary/Contact Us/Request a Brochure/501 C 3 Letter /Site Map
ALZinfo.org Media Kit

© 2002 - 2009 The Fisher Center for Alzheimer's Research Foundation, a 501c3 not for profit, Tax ID # 13-3859563.


This project was supported, in part, by a grant, number 90AZ2791, from the Administration on Aging, Department of Health and Human Services, Washington, D.C. 20201. Grantees undertaking projects under government sponsorship are encouraged to express freely their findings and conclusions. Points of view or opinions do not, therefore, necessarily represent official Administration on Aging policy.